These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 6762234)
21. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE; Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163 [TBL] [Abstract][Full Text] [Related]
22. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038 [TBL] [Abstract][Full Text] [Related]
23. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680 [TBL] [Abstract][Full Text] [Related]
24. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial. Christensen SB; Jansson C Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890 [TBL] [Abstract][Full Text] [Related]
25. [Sentinel lymph node biopsy with micrometastases in breast cancer: histological data and surgical implications. About a series of 201 axillary dissections after peroperative sentinel node identification]. Marin C; Mathelin C; Neuville A; Mertz L; Constantinesco A; Chenard MP; Bellocq JP Bull Cancer; 2003 May; 90(5):459-65. PubMed ID: 12850769 [TBL] [Abstract][Full Text] [Related]
26. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455 [TBL] [Abstract][Full Text] [Related]
27. Rationale of lymph node dissection for breast cancer--from the viewpoint of analysis of axillary lymphatic flow using activated carbon particle CH40. Sawai K; Hagiwara A; Shimotsuma M; Sakakibara T; Imanishi T; Takemoto Y; Takahashi T Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():30-5. PubMed ID: 8702308 [TBL] [Abstract][Full Text] [Related]
28. [The role of the histopathological analysis of sentinel lymph nodes in breast cancer. Preliminary findings]. Cserni G; Boross G; Baltás B Orv Hetil; 1998 Aug; 139(32):1899-903. PubMed ID: 9731445 [TBL] [Abstract][Full Text] [Related]
29. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer. Choi YJ; Yun HR; Yoo KE; Kim JH; Nam SJ; Choi YL; Ko YH; Kim BT; Yang JH Jpn J Clin Oncol; 2006 Aug; 36(8):489-93. PubMed ID: 16790449 [TBL] [Abstract][Full Text] [Related]
30. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer. Ishikawa T; Miyajima E; Sasaki T; Tanabe M; Matsumoto C; Nozawa A; Kawachi K; Fukuno Y; Takeda H; Hayashi T; Onaka S; Momiyama N; Ichikawa Y; Inui K; Shimada H Eur J Surg Oncol; 2007 May; 33(4):430-4. PubMed ID: 17101257 [TBL] [Abstract][Full Text] [Related]
32. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A Breast J; 2006; 12(4):294-301. PubMed ID: 16848838 [TBL] [Abstract][Full Text] [Related]
33. Asymmetries in breast cancer lateralization and both axillary lymph node number and metastatic involvement. Dane S; Yildirim S; Koc M; Aktan M; Gundogdu C Lymphology; 2008 Jun; 41(2):75-9. PubMed ID: 18720914 [TBL] [Abstract][Full Text] [Related]
34. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968 [TBL] [Abstract][Full Text] [Related]
35. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127 [TBL] [Abstract][Full Text] [Related]
36. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer. Petrik DW; McCready DR; Sawka CA; Goel V J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062 [TBL] [Abstract][Full Text] [Related]
37. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438 [TBL] [Abstract][Full Text] [Related]
38. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464 [TBL] [Abstract][Full Text] [Related]
39. Axillary lymph node dissection: does it have a role in primary breast cancer? Pack MS; Thomas RS Am Surg; 1996 Feb; 62(2):159-61. PubMed ID: 8554194 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of cytokeratin-positive breast cancer metastases. Sedmak DD; Meineke TA; Knechtges DS; Anderson J Mod Pathol; 1989 Sep; 2(5):516-20. PubMed ID: 2479008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]